Pilot Study of Lymphoid Tumor Microenvironmental Dysruption Prior to Autologous Stem Cell Transplantation
Condition(s):Chronic Lymphocytic Leukemia; Lymphoma; Multiple MyelomaLast Updated:May 9, 2017Terminated
Hide Studies Not Open or Pending
Condition(s):Chronic Lymphocytic Leukemia; Lymphoma; Multiple MyelomaLast Updated:May 9, 2017Terminated
Condition(s):Solid Tumor; Brain Tumor; LymphomaLast Updated:July 14, 2015Completed
Condition(s):LymphomaLast Updated:July 14, 2020Completed
Condition(s):Left Ventricular DysfunctionLast Updated:June 30, 2015Completed
Condition(s):LymphomaLast Updated:May 15, 2019Completed
Condition(s):End Stage Liver DiseaseLast Updated:January 19, 2021Unknown status
Condition(s):Acute Myeloid Leukemia; Minimal Residual Disease NegativityLast Updated:February 1, 2021Withdrawn
Condition(s):Lupus Erythematosus, SystemicLast Updated:January 5, 2021Completed
Condition(s):Hematopoietic Stem Cell TransplantationLast Updated:August 30, 2021Completed
Condition(s):Leukemia; Lymphoma; Multiple Myeloma; Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myeloproliferative NeoplasmsLast Updated:July 1, 2016Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.